news Google’s AI co-scientist accelerates drug development 7 March 2025 | By Drug Target Review Google has introduced an AI-powered 'co-scientist' designed to accelerate biomedical research and drug discovery by generating scientific hypotheses and identifying novel therapeutic targets.
news AI-designed CDK12/13 inhibitors target resistant cancers 5 March 2025 | By Drug Target Review Insilico Medicine’s AI-designed CDK12/13 inhibitors show promise against treatment-resistant cancers. Find out how this breakthrough could reshape cancer therapy.
news New predictive model identifies synergistic drug pairings 25 February 2025 | By Drug Target Review Researchers at Mount Sinai have created a computational tool that predicts effective drug combinations, providing a faster and more cost-efficient method for identifying potential treatments for complex diseases like cancer.
news FORESIGHT consortium secures €9 million to fast-track drug development 24 February 2025 | By Drug Target Review The FORESIGHT consortium has secured €9 million to speed up drug development using advanced molecular imaging, targeting major diseases like cancer, autoimmune conditions, and heart disorders.
article Large language models: now more affordable and reliable than ever 24 February 2025 | By Dr Raminderal Singh (Hitchhikers AI and 20/15 Visioneers In this article, Dr Raminderpal Singh explores the transformative impact of the Deepseek R1 open-source large language model on drug discovery. Its potential offers exciting opportunities for both scientists and software developers, marking a significant advancement for the life sciences community.
news Capgemini’s AI innovation set to boost bioeconomy 17 February 2025 | By Drug Target Review Capgemini's new AI-powered methodology reduces data requirements by 99 percent and accelerates bioengineering breakthroughs, including improved plastic degradation and faster drug discovery.
article Using clinical genomics and AI in drug development to elevate success 11 February 2025 | By Alessio Zoccoli, Carlos N Velez, Remco Jan Geukes Foppen, Vincenzo Gioia How are clinical genomics and AI transforming drug development? Industry experts reveal how these technologies improve target identification, patient stratification, and trial design to drive higher success rates.
article New study links type 2 diabetes to accelerated cognitive decline 6 February 2025 | By Drug Target Review Study reveals how type 2 diabetes accelerates cognitive decline by damaging white matter in the brain. Sam Hashemi at Prenuvo explains how advanced AI and whole-body MRI technology are opening new possibilities for early intervention.
news AI designs peptides for ‘undruggable’ diseases 4 February 2025 | By Drug Target Review A new AI-powered approach is tackling the challenge of 'undruggable' diseases by designing peptides that can bind to and destroy previously untreatable proteins.
webinar The future of carcinogenicity risk assessment: AI-powered, ethical alternatives to traditional testing 29 January 2025 | By Eurofins Discovery Explore how a Weight of Evidence (WoE) approach uses in vitro methods and artificial intelligence (AI) to transform carcinogenicity risk assessment, reducing reliance on animal studies while enhancing compliance with FDA and ICH guidelines.
article Scientific workflow for hypothesis testing in drug discovery: Part 2 of 3 14 January 2025 | By Dr Raminderal Singh (Hitchhikers AI and 20/15 Visioneers, Nina Truter In part two of the step-by-step scientific workflow for drug discovery series, Dr Raminderpal Singh and Nina Truter describe the functions of the workflow previously outlined and include key considerations.
news Boltz-1: A new open-source AI tool for drug discovery 31 December 2024 | By Drug Target Review MIT's new open-source AI model, Boltz-1, could transform drug discovery by accurately predicting protein structures, offering global access to researchers.
article How AI will reshape pharma in 2025 20 December 2024 | By Carrie Haslam AI is set to transform drug development in 2025, streamlining processes and opening new possibilities. Learn how this technology is transforming clinical trials and reshaping the pharmaceutical industry.
article Oncology advances through the lens of women in STEM 16 December 2024 | By Dr. Pooja Hingorani (Senior Medical Director of Oncology Early Development at AbbVie) Dr Pooja Hingorani opens up about her journey in oncology research, the obstacles she’s overcome as a woman in STEM, and her mission to transform cancer care.
podcasts Overcoming obstacles in personalised medicine 11 December 2024 | By Drug Target Review Tune in to this episode to learn how overcoming the key challenges in personalised medicine could transform the future of healthcare.
